Clinical Trials
Enrollment opened in phase 2 trial of DNA vaccine against cytomegalovirus
Published in Medical Letter on the CDC and FDA, March 5th, 2006
Success in this patient population would support Vical's expansion of studies of its CMV vaccine into other transplant settings and the general population.
CMV is a herpes virus that infects more than half of all adults in the United States by age 40, and is even more widespread in developing countries. While a healthy immune system typically protects an infected person against CMV disease, it rarely...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Anthrax Vaccines
Effects of storage on plasmid stability in Bacillus anthracis are reported - Epidemiology
Prevalence of Staphylococcus aureus nasal colonization is high in U.S. - Epidemiology
Report examines prevalence of hepatitis A virus infection in U.S. population - HIV/AIDS Risk Factors
Effectiveness of community outreach to prevent HIV/AIDS in drug users is examined - HIV/AIDS Risk Factors
Report presents results of the Expanded HIV Risk Factor Assessment Project - Addiction Medicine
Depictions of substance use in reality television send mixed messages - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
